Health

A daily pill nearly doubled survival for patients with stage 4 pancreatic cancer in a landmark trial, and US hospitals have begun offering it ahead of FDA approval. Patients on daraxonrasib lived a median of 13.2 months, compared with 6.7 months on standard intravenous chemotherapy.

The Ebola outbreak sweeping the Democratic Republic of Congo has now killed more than 2,000 people, with 4,381 confirmed cases according to published government data. The outbreak is driven by the Bundibugyo strain, a variant genetically distinct from the virus behind the 2014 crisis, and that difference is undermining the treatments and vaccines the world spent a decade building. Experts say the risk to Americans remains extremely low, but the situation on the ground is deteriorating fast.

Louisiana has confirmed five deaths from the flesh-eating bacterium Vibrio vulnificus in 2026, a sharp jump from the single fatality the state typically records by this point in the year. Nine residents have been infected so far, and every one of them ended up in the hospital. State health officials are now urging swimmers to stay cautious in coastal waters through the warm months.